Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (56)
- Committees and advisory bodies (45)
- Safety monitoring and information (12)
- Advertising (9)
- Manufacturing (9)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Clinical trials (3)
- Legislation (3)
- Medicinal cannabis hub (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
247 result(s) found, displaying 26 to 50
-
Corporate reportsDocuments released under the FOI Act in the 2023/24 financial year
-
Corporate reportsThis Cost Recovery Implementation Statement (CRIS) 2024-2025 provides information on how we implement, and cost recover our regulatory activities.
-
Corporate reportsThis framework outlines our processes to identify and manage risk relating to breast implants.
-
Corporate reportsThis fact sheet is for healthcare practitioners to help understand the rules surrounding importation of cosmetic injectables.
-
Corporate reportsThe report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
Corporate reportsFind out about the seasonal influenza vaccines available for the 2024 southern hemisphere season.
-
Scheduling submissionsFind out about the public submissions on interim decisions for scheduling matters referred to the ACMS #43, ACCS #37 and Joint ACMS-ACCS #35 meetings held in November 2023
-
Corporate reportsThis guide applies to the manufacture of medicines, active pharmaceutical ingredients and sunscreens, unless exempt under provisions in the Therapeutic Goods Act 1989.
-
Corporate reportsAn overview of the Medicines Repurposing Program's purpose and history.
-
Corporate reportsThis publication outlines our plan to transition to a paperless model for Special Access Scheme (SAS) and Authorised Prescriber (AP) submissions. From 1 July 2024 we will only accept submissions via the SAS/AP Online System.
-
Corporate reportsThis report provides information about our regulatory performance from 1 July 2022 to 30 June 2023.
-
Scheduling submissionsFind out about the public submissions on interim decisions for scheduling matters referred to the ACMS #42 and Joint ACMS-ACCS #34 meetings held in June 2023.
-
Corporate reportsWe survey our stakeholders each year to help evaluate our performance and identify ways of improving.
-
Corporate reportsRead our 2023 stakeholder survey report, which aims to improve the way we work with our stakeholders.
-
Corporate reportsMedical Devices Safety Update (MDSU) provides practical advice and information about medical device safety.
-
Corporate reportsThe strategy outlines the approach we will use to identify, engage with, and educate stakeholders about regulatory requirements and our compliance outcomes.
-
Scheduling submissionsFind out about public submissions on scheduling matters referred to Advisory Committees meeting, held in June 2023
-
Corporate reportsOverview of therapeutic goods advertising complaints handling and compliance for 2022-23
-
Corporate reportsAccess our report on medical devices manufactured at the point-of-care - analysis of survey results by sector.
-
Scheduling submissionsFind out about public submissions on interim decisions for scheduling matters referred to Advisory Committees meetings, held in March 2023
-
Corporate reportsRead our business plan 2023-24 to find out about our strategic priorities and activities.
-
Corporate reportsDocuments released under the FOI Act in the 2022/23 financial year
-
Scheduling submissionsFind out about public submissions on scheduling matters referred to Advisory Committees meetings, held in March 2022.
-
Scheduling submissionsFind out about public submissions on interim decisions for scheduling matters referred to Advisory Committees meetings, held in March 2022.
-
Scheduling submissionsFind out about public submissions on scheduling matters referred to Advisory Committees meeting, held in March 2023